Tuis4568 • TYO
add
Daiichi Sankyo Co Ltd
Vorige sluiting
ÂĄ3Â 100,00
Dagwisseling
ÂĄ3Â 110,00 - ÂĄ3Â 228,00
Jaarwisseling
ÂĄ3Â 036,00 - ÂĄ6Â 257,00
Markkapitalisasie
6,13Â bn JPY
Gemiddelde volume
6,66Â m
P/V-verhouding
24,93
Dividend-opbrengs
1,87%
PrimĂŞre beurs
TYO
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(JPY) | Des. 2024info | J/J-verandering |
---|---|---|
Inkomste | 484,84Â mjd | 8,48% |
Bedryfskoste | 295,04Â mjd | 31,08% |
Netto inkomste | 61,93Â mjd | -6,96% |
Netto winsgrens | 12,77 | -14,24% |
Wins per aandeel | — | — |
EBITDA | 78,78Â mjd | -31,17% |
Effektiewe belastingkoers | 24,86% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(JPY) | Des. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 682,15Â mjd | 2,31% |
Totale bates | 3,44Â bn | 5,34% |
Totale aanspreeklikheid | 1,82Â bn | 8,17% |
Totale ekwiteit | 1,62 bn | — |
Uitstaande aandele | 1,88 mjd | — |
Prys om te bespreek | 3,59 | — |
Opbrengs op bates | 4,56% | — |
Opbrengs op kapitaal | 8,90% | — |
Kontantvloei
Netto kontantverandering
(JPY) | Des. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 61,93Â mjd | -6,96% |
Kontant van bedrywe | 58,28Â mjd | -90,80% |
Kontant van beleggings | 20,67Â mjd | 104,27% |
Kontant van finansiering | -133,08Â mjd | -213,54% |
Netto kontantverandering | -25,52Â mjd | -133,59% |
Beskikbare kontantvloei | -11,41Â mjd | 97,14% |
Meer oor
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
HUB
Gestig
28 Sep. 2005
Hoofkwartier
Webwerf
Werknemers
18Â 726